Enzalutamide With Radiation Therapy for Intermediate-Risk Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Phase II Study of Enzalutamide With Radiation Therapy for Intermediate Risk Prostate Cancer: A Phase 2 Study
Int. J. Radiat. Oncol. Biol. Phys 2021 Feb 23;[EPub Ahead of Print], GJ Bubley, I Kaplan, R Bhatt, ME Taplin, S Dowling, K Mahoney, E Werner, EP NguyenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.